Citations

Showing 10 of 108119 citations.

Radial Head Prosthetic Replacement in Adolescents: A Report of 5 Cases
Rotman, Dani , Liévano, Jorge Rojas , O’Driscoll, Shawn W. , Rojas Lievano, Jorge, Kwak, Jae-Man, O'Driscoll, Shawn W., Fitzsimmons, James S , Kwak, Jae‐Man , Lievano, Jorge Rojas

Mayo Clinic

Journal of Pediatric Orthopaedics | December 7, 2021 | Volume: 42 | Issue: 2 | Pages: 109-115

10.1097/bpo.0000000000002030 | PMID 34873116 Get It

Background: The management of severe radiocapitellar joint pathologies in young patients is challenging. Radial head arthroplasty (RHA) is a treatment option in the adult population, but most surgeons avoid implementing it in younger patients, and there are no published results for patients younger than 16 years. Methods: Our retrospective cohort describes 5 patients (4 male 1 female) who underwent cementless modular RHA at an average age of 14 years (range: 13 to 15). The preoperative diagnoses were post-traumatic radiocapitellar incongruity and arthrosis because of previous Salter-Harris type 3 or 4 fractures of the radial head in 3 cases; and axial instability of the forearm following failed radial head excision in 2 cases. Because of the complexity of the elbow pathology in these cases, all underwent concomitant procedures including: contracture release (5 cases), corrective ulnar osteotomy (2 cases), distal ulnar shortening osteotomy, excision of radioulnar synostosis, microfracture of the capitellum, and partial excision of the medial triceps (1 case each). Collected data included patient-reported outcomes, visual analog scale pain score at rest and during physical activity and radiographic assessment of arthritis and prosthesis loosening. Results: Average clinical follow-up was 8 years (range: 3 to 13). All 5 patients were pain-free at rest, and 3 reported moderate elbow pain (visual analog scale: 5 to 6) with physical activity. At an average radiographic follow-up of 3 years (range: 0.5 to 5), 3 patients showed mild progression of elbow arthrosis, but there were no signs of progressive capitellar erosion or implant loosening. Only 1 complication was noted—development of heterotopic ossification in 1 patient, which required open heterotopic ossification excision and contracture release 2 years following the RHA. None of the patients required prosthesis revision or removal. Conclusion: RHA was successful in improving pain and axial forearm stability in this very small series of adolescent patients. Concerns regarding long-term longevity and complications still exist. Considering the lack of other reliable treatment options, RHA may be indicated in this challenging patient population. Level of Evidence: Level IV: therapeutic study—case series.
Perceived Experiences of Korean Immigrant Mothers Raising Children With Disabilities in the United States
Lee, Anna , Yeh, Vicky J.-H. , Knafl, Kathleen Astin , Riper, Marcia L. Van

Mayo Clinic

Journal of Transcultural Nursing | December 7, 2021 | Volume: 33 | Issue: 2 | Pages: 219-227

10.1177/10436596211062935 | PMID 34872416 Get It

Introduction: The challenges of acculturation that immigrant families experience could intensify if they have a child with a disability. This qualitative descriptive study aimed to describe the experiences of Korean mothers raising children with a disability in the United States. Methodology: Semi-structured interviews were conducted based on the Resilience Model of Family Stress, Adjustment, and Adaptation. Directed content analysis was used. Results: Six Korean mothers participated in the interview and 16 codes were identified in relation to the five concepts of the Resilience Model, namely family demands, family resources, family appraisal, family problem-solving and coping, and family adaptation. Overall, mothers thought their families were well-functioning and viewed their quality of life positively within the context of immigration despite experiencing various family demands. Discussion: Findings of this study showed the resilience of Korean immigrant mothers and revealed the importance of understanding and considering unique cultural differences when providing care to this population.
Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID
Weaver, Kimberly N. , Zhang, Xian , Dai, Xiangfeng , Watkins, Runa , Adler, Jeremy, Dubinsky, Marla C. , Kastl, Arthur , Bousvaros, Athos, Strople, Jennifer , Cross, Raymond K. , Higgins, Peter , Bewtra, Meenakshi , Bellaguarda, Emanuelle, Boccieri, Margie , Firestine, Ann M. , Long, Millie D. , Cross, Raymond , Adler, Jeremy, Ungaro, Ryan C. , Farraye, Francis A. , Kappelman, Michael D. , Adler, J

Mayo Clinic

Inflammatory Bowel Diseases | December 6, 2021 | Volume: 28 | Issue: 10 | Pages: 1497-1505

10.1093/ibd/izab302 | PMID 34871388 Get It

Abstract Background Severe acute respiratory syndrome coronavirus 2 vaccination is recommended for all individuals with inflammatory bowel disease (IBD), including those on immunosuppressive therapies; however, little is known about vaccine safety and efficacy in these patients or the impact of vaccination on IBD disease course. Methods We evaluated coronavirus disease 2019 (COVID-19) vaccine–related adverse events (AEs) and the effect of vaccination on IBD disease course among participants in the PREVENT-COVID (Partnership to Report Effectiveness of Vaccination in populations Excluded from iNitial Trials of COVID) study, a prospective, observational cohort study. Localized and systemic reactions were assessed via questionnaire. Disease flare was defined by worsening IBD symptoms and change in IBD medications. Outcomes were stratified by vaccine type and IBD medication classes. Results A total of 3316 individuals with IBD received at least 1 COVID-19 vaccine. Injection site tenderness (68%) and fatigue (46% dose 1, 68% dose 2) were the most commonly reported localized and systemic AEs after vaccination. Severe localized and systemic vaccine-related AEs were rare. The mRNA-1273 vaccine was associated with significantly greater severe AEs at dose 2 (localized 4% vs 2%, systemic 15% vs 10%; P < .001 for both). Prior COVID-19 infection, female sex, and vaccine type were associated with severe systemic reactions to dose 1, while age <50 years, female sex, vaccine type, and antitumor necrosis factor and vedolizumab use were associated with severe systemic reactions to dose 2. Overall rates (2%) of IBD flare were low following vaccination. Conclusions Our findings provide reassurance that the severe acute respiratory syndrome coronavirus 2 vaccine is safe and well tolerated among individuals with IBD, which may help to combat vaccine hesitancy and increase vaccine confidence.
Comparison of Five Common Analyzers in the Measurement of Chemistry Analytes in an Authentic Cohort of Body Fluid Specimens
Block, Darci R , Cotten, Steven W. , Franke, Deanna, Mbughuni, Michael M.

Mayo Clinic

American Journal of Clinical Pathology | December 6, 2021 | Volume: 158 | Issue: 1 | Pages: 47-61

10.1093/ajcp/aqab218 | PMID 35099516 Get It

Abstract Objectives Interpretation of body fluid (BF) results is based on published studies and clinical guidelines. The aim of this study is to determine whether the assays from five common commercial vendors produce similar results in BFs for 12 analytes in a BF cohort. Methods BFs (n = 25) and serum (n = 5) were analyzed on five instruments (Roche cobas c501, Ortho 5600, Beckman AU5800 and DXI800, Siemens Vista 1500, and Abbott Architect c8000) to measure albumin, amylase, total bilirubin, cholesterol, creatinine, glucose, lactate dehydrogenase (LDH), lipase, total protein, triglycerides, urea nitrogen, and carcinoembryonic antigen. Deming regression and Bland-Altman analysis were used for method comparison to Roche. Results Results were significantly different from Roche for LDH and lipase on Ortho and lipase on Siemens but similar for both BFs and serum. BF differences were larger than serum differences when measuring creatinine, glucose, and urea nitrogen on Ortho and glucose on Siemens. Conclusions Five instruments used to perform BF testing produce results that are not significantly different except for lipase and LDH measurements. Bias of similar magnitude observed in both BF and serum should not affect interpretation. Further investigations into Ortho and Siemens measuring glucose and Ortho measuring creatinine and urea nitrogen are warranted.
Definition of competence standards for optical diagnosis of diminutive colorectal polyps: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement
Houwen, Britt B. S. L. , Hassan, Cesare , Greuter, Marjolein J.E. , Hazewinkel, Yark, Vleugels, Jasper L.A., Antonelli, Giulio , Bustamante, Marco , Coron, Emmanuel , Cortas, George, Dinis‐Ribeiro, Mário , Dobru, Daniela , Iacucci, Marietta , Jover, Rodrigo , Kuvaev, Roman , Neumann, Helmut , Rutter, Matthew D. , Saunders, Brian P. , Tate, David J. , Bisschops, Raf , Dekker, Evelien , Bustamante-Balén, Marco , Neumann, Helmut , Pellisé, Maria , Puig, Ignasi , Rutter, Matthew D , Mori, Yuichi , Bisschops, Raf , Dekker, Evelien , Hassan, Cesare , Iacucci, Marietta , Coupé, Veerle M.H. , East, James E. , Mori, Yuichi , Longcroft‐Wheaton, Gaius

Mayo Clinic

Endoscopy | December 6, 2021 | Volume: 54 | Issue: 01 | Pages: 88-99

10.1055/a-1689-5130 | PMID 34872120 Get It

Abstract Background The European Society of Gastrointestinal Endoscopy (ESGE) has developed a core curriculum for high quality optical diagnosis training for practice across Europe. The development of easy-to-measure competence standards for optical diagnosis can optimize clinical decision-making in endoscopy. This manuscript represents an official Position Statement of the ESGE aiming to define simple, safe, and easy-to-measure competence standards for endoscopists and artificial intelligence systems performing optical diagnosis of diminutive colorectal polyps (1 – 5 mm). Methods A panel of European experts in optical diagnosis participated in a modified Delphi process to reach consensus on Simple Optical Diagnosis Accuracy (SODA) competence standards for implementation of the optical diagnosis strategy for diminutive colorectal polyps. In order to assess the clinical benefits and harms of implementing optical diagnosis with different competence standards, a systematic literature search was performed. This was complemented with the results from a recently performed simulation study that provides guidance for setting alternative competence standards for optical diagnosis. Proposed competence standards were based on literature search and simulation study results. Competence standards were accepted if at least 80 % agreement was reached after a maximum of three voting rounds. Recommendation 1 In order to implement the leave-in-situ strategy for diminutive colorectal lesions (1–5 mm), it is clinically acceptable if, during real-time colonoscopy, at least 90 % sensitivity and 80 % specificity is achieved for high confidence endoscopic characterization of colorectal neoplasia of 1–5 mm in the rectosigmoid. Histopathology is used as the gold standard. Level of agreement 95 %. Recommendation 2 In order to implement the resect-and-discard strategy for diminutive colorectal lesions (1–5 mm), it is clinically acceptable if, during real-time colonoscopy, at least 80 % sensitivity and 80 % specificity is achieved for high confidence endoscopic characterization of colorectal neoplasia of 1–5 mm. Histopathology is used as the gold standard. Level of agreement 100 %. Conclusion The developed SODA competence standards define diagnostic performance thresholds in relation to clinical consequences, for training and for use when auditing the optical diagnosis of diminutive colorectal polyps.
Identifying and Addressing Health Disparities in Thyroid Cancer Care
Asamoah, Ernest, Caraballo, Graciela , Castro, M. Regina

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | December 6, 2021 | Volume: 107 | Issue: 5 | Pages: e2190-e2191

10.1210/clinem/dgab875 | PMID 34871424 Get It

Liver Iron Concentration Assessed by SQUID Biosusceptometry Compared to Heat-dried Liver Biopsy: A Blinded Study.
Weyhmiller, Marcela , Pakbaz, Zahra, Butz, John A., Fung, Ellen B. , Paulson, D. N. , Pratt, Kevin , Rowland, Jon, Lal, Ashutosh , Harmatz, Paul , Vichinsky, Elliott P. , Fischer, Roland

Mayo Clinic

No container title available | December 6, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1135845/v1 Get It

Abstract Objective Biomagnetic liver susceptometry (BLS) is a noninvasive method to quantify liver iron concentration (LIC). Here we report our findings from a prospective study which validates in vivo LIC from a SQUID biosusceptometer by in vitro LIC in fresh tissue and paraffin-embedded biopsies from patients at risk for iron overload.Materials and Methods LIC was measured by BLS and biopsy. LIC by biopsy were measured in 40 dry weight fresh tissue and paraffin-embedded liver biopsy samples. LIC from biopsies and total iron scores from histology were compared to biosusceptometry. In addition, the wet-to-dry weight ratio was determined.Results Liver iron concentrations measured by BLS and in 40 fresh tissue biopsies were related by a factor of 6.0 ± 0.2 (r2 = 0.88). Similar results were obtained from comparisons with deparaffinized biopsies (6.6±0.3, r2=0.87) and histology (6.7±1.3, r2=0.47). In contrast, a mean wet-to-dry weight ratio of 4.1 ± 0.7 was achieved from biopsies immediately weighed after the biopsy procedure.ConclusionLIC derived from two independent measures, the historical biopsy gold standard and biosusceptometry, were highly correlated. When comparing biosusceptometry with wet weight biopsies, the liver tissue sample size is critical.
A clinical laboratory–developed LSC17 stemness score assay for rapid risk assessment of patients with acute myeloid leukemia
Ng, Stanley , Murphy, Tracy , Mah, Michelle , Lu, Zhibin , Stickle, Natalie , Ibrahimova, Narmin, Arruda, Andrea , Mai, Ming, He, Rong , Madala, Bindu Swapna , Viswanatha, David S., Dick, John E. , Chan, Steven M. , Virtanen, Carl , Minden, Mark D. , Mercer, Tim R. , Wang, Jean , Lu, Zhibin , He, Rong , Madala, Bindu Swapna , Dick, John E , Virtanen, Carl , Minden, Mark D , Mercer, Timothy , Stockley, Tracy , Wang, Jean C Y , King, Ian F. G. , Zhang, Tong , Mitchell, Amanda

Mayo Clinic

Blood Advances | December 6, 2021 | Volume: 6 | Issue: 3 | Pages: 1064-1073

10.1182/bloodadvances.2021005741 | PMID 34872104 Get It

Abstract Leukemia stem cells (LSCs) are linked to relapse in acute myeloid leukemia (AML). The LSC17 gene expression score robustly captures LSC stemness properties in AML and can be used to predict survival outcomes and response to therapy, enabling risk-adapted, upfront treatment approaches. The LSC17 score was developed and validated in a research setting. To enable widespread use of the LSC17 score in clinical decision making, we established a laboratory-developed test (LDT) for the LSC17 score that can be deployed broadly in clinical molecular diagnostic laboratories. We extensively validated the LSC17 LDT in a College of American Pathologists/Clinical Laboratory Improvements Act (CAP/CLIA)-certified laboratory, determining specimen requirements, a synthetic control, and performance parameters for the assay. Importantly, we correlated values from the LSC17 LDT to clinical outcome in a reference cohort of patients with AML, establishing a median assay value that can be used for clinical risk stratification of individual patients with newly diagnosed AML. The assay was established in a second independent CAP/CLIA-certified laboratory, and its technical performance was validated using an independent cohort of patient samples, demonstrating that the LSC17 LDT can be readily implemented in other settings. This study enables the clinical use of the LSC17 score for upfront risk-adapted management of patients with AML.
Women's Health Endocrinology Update
Kapoor, Ekta , Kling, Juliana M. , Kling, Juliana M , Kapoor, Ekta , Faubion, Stephanie S.

Mayo Clinic

Journal of Women's Health | December 6, 2021 | Volume: 30 | Issue: 12 | Pages: 1681-1685

10.1089/jwh.2021.0460 | PMID 34871065 Get It

Patterns of Delirium in a Pediatric Intensive Care Unit and Associations With Noise Pollution
Weatherhead, Jeffrey , Niedner, Matthew , Dahmer, Mary K. , Malas, Nasuh , Owens, Toni, Kawai, Yu , Weatherhead, Jeffrey R , Kawai, Yu , Owens, Tonie

Mayo Clinic

Journal of Intensive Care Medicine | December 6, 2021 | Volume: 37 | Issue: 7 | Pages: 946-953

10.1177/08850666211055649 | PMID 34870515 Get It

Objective: Delirium is a common problem in the Pediatric Intensive Care Unit (PICU) and is associated with increased length of stay, cost and mortality. This study evaluated the relationship between noise pollution and delirium risk. Design: This is a Quality Improvement (QI) initiative at an academic PICU. Sound levels were monitored and patients were screened for delirium using the Cornell Assessment of Pediatric Delirium (CAPD). Setting PICU Patients: All PICU patients Interventions: None Measurements and Main Results: Over the 83-week study period (2015-2017), the median [IQR] CAPD score was 8 [3 to 14]. Nursing compliance with the CAPD was 72.2%. The proportion of patients screening positive for delirium (CAPD ≥ 9) was 45.9%. A total of 329 711 hly decibel (dB) measurements were collected and reported. Occupied rooms were louder than unoccupied rooms (51.8 [51.6-51.9] dB vs. 49.8 [49.7-49.9] dB, respectively, p < 0.001). Days (10 AM to 4 PM) were louder than nights (11 PM to 5 AM) (52.8 [52.7-53.0] dB vs. 50.7 [49.9-51.5] dB, respectively p < 0.001) in occupied rooms. Winter (Nov-Feb) months were louder than summer (May-Aug) months (52.0 [51.8-52.3] dB vs. 51.5 [51.3-51.7] dB, respectively, p < 0.002) in occupied rooms. Median weekly nighttime noise levels and CAPD scores demonstrated a correlation coefficient of 0.6 ( p < 0.001). Median weekly risk of mortality (ROM) and CAPD scores demonstrated a correlation coefficient of 0.15 ( p < 0.01). Conclusions: Significant noise pollution exists in the PICU with a moderate correlation between nighttime noise levels and CAPD scores. This could potentially implicate noise pollution as a risk factor for the development of delirium.